Background illustration for clinical trials search

Paid Clinical Trials Dover

Discover 265 paid clinical trials in Dover, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Light Therapy Intervention in Individuals With Parkinson's Disease

for
Parkinson Disease
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 50 - 70+

Code: NCT06916260

Recruiting

FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device

for
Stroke, Gait
Location: Newark DE
Sponsor: customKYnetics

Sex: All

Age: 21 - 70+

Code: NCT02032329

Phase 1, Phase 2, Recruiting

Pain and Split-belt Motor Learning in Older Adults

for
Aging, Older Adults, Pain, Motor Learning
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 55 - 70+

Code: NCT07054840

Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Newark DE, Camden NJ, Philadelphia PA, Baltimore MD,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

Determinants of Changes in Arterial Load Following Exercise

for
Post-Exercise Hypotension
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18 - 45

Code: NCT05820243

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics

for
Sodium Excess
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 21 - 45

Code: NCT04233957

Recruiting

Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease

for
Chronic Kidney Disease
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18+

Code: NCT02364648

Recruiting

Mechanical Perturbation Training for ACL Injury Prevention

for
Anterior Cruciate Ligament Injury, ACL
Location: Newark DE
Sponsor: University of Delaware

Sex: Female

Age: 15 - 30

Code: NCT03080402

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Newark DE, Camden NJ, York PA, Bethesda MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Newark DE, Baltimore MD, Lancaster PA, Brandywine MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Newark DE, Arlington VA, New Brunswick NJ, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for
Gastroesophageal Adenocarcinoma
Location: Newark DE, Washington D.C. DC, Pittsburgh PA, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07069712

Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Newark DE, Pomona NJ, Philadelphia PA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Newark DE, Baltimore MD, Camden NJ, York PA, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Newark DE, Philadelphia PA, Towson MD, Silver Spring MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase 3, Recruiting
New

Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation

for
Recurrent Soft Tissue Sarcoma of the Trunk and Extremities,
Location: Newark DE, Chadds Ford PA, Philadelphia PA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07615049

Phase 3, Recruiting

Vitamin D for Prostate Endocrine Therapy

for
Stage I Prostate Cancer AJCC v8,
Location: Newark DE, Wilkes-Barre PA, Mechanicsville VA,
Sponsor: University of Rochester

Sex: Male

Age: 50+

Code: NCT05838716

Phase 3, Recruiting

Statins and Breast Cancer Biomarkers

for
Breast Cancer
Location: Newark DE, Durham NC, Goldsboro NC, Boston MA,
Sponsor: University of Vermont

Sex: Female

Age: 35 - 55

Code: NCT00914017

Phase 2, Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Newark DE, New York NY, Hackensack NJ, The Bronx NY,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase 1, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Newark DE, Philadelphia PA, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting